Home > Journals > Gazzetta Medica Italiana Archivio per le Scienze Mediche > Past Issues > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2017 April;176(4) > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2017 April;176(4):149-53

CURRENT ISSUE

JOURNAL TOOLS

Publishing options

Submit an article

Recommend to your librarian

ARTICLE TOOLS

Publication history

Cite this article as

ORIGINAL ARTICLE

Gazzetta Medica Italiana Archivio per le Scienze Mediche 2017 April;176(4):149-53

DOI: 10.23736/S0393-3660.16.03444-6

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Effects of a novel MYRLIQ®, Ginkgo Biloba, Q10 and vitamin B2 (riboflavin) based nutraceutical in patients suffering from migraine headache without aura or sporadic episodes of tension-type headache. A six-month pilot study

Leonardo SCARZELLA ^{1, 2} ✉

ACCESS OPTIONS

Purchase access

You can access the full text of this article (PDF and HTML if available) for 48 hours at a price of € 200,00.

Downloading and printing for personal use allowed.

Personal subscriptions

Access as an individual subscriber

Institutional access

Access through your institution

Subscribe to this journal

Subscribe to Gazzetta Medica Italiana Archivio per le Scienze Mediche

Recommend to your librarian